Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,609 | 56,911 | 90,541 | 159,570 | 191,173 |
| Marketable Securities | 34,929 | 54,999 | 67,039 | 43,250 | 66,505 |
| Receivables | 40,303 | 41,103 | 35,499 | 43,086 | 42,615 |
| Inventories | 61,318 | 56,470 | 48,382 | 41,502 | 42,800 |
| TOTAL | $194,209 | $222,593 | $254,423 | $315,052 | $366,826 |
| Non-Current Assets | |||||
| PPE Net | 23,468 | 23,858 | 23,734 | 22,788 | 22,175 |
| Other Non-Current Assets | 26,288 | 27,272 | 27,549 | 14,548 | 15,249 |
| TOTAL | $49,756 | $51,130 | $51,283 | $37,336 | $37,424 |
| Total Assets | $243,965 | $273,723 | $305,706 | $352,388 | $404,250 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,804 | 8,226 | 3,803 | 5,885 | 11,242 |
| Accrued Expenses | 59,993 | 82,291 | 38,979 | 33,157 | 37,588 |
| TOTAL | $109,498 | $93,001 | $71,058 | $72,296 | $82,143 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 156,203 | 156,764 | 157,078 | 161,249 | 161,995 |
| TOTAL | $156,203 | $156,764 | $157,078 | $161,249 | $161,995 |
| Total Liabilities | $265,701 | $249,765 | $228,136 | $233,545 | $244,138 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,632 | 102,480 | 102,141 | 101,935 | 101,910 |
| Common Shares | 1,025 | 1,021 | 1,020 | 1,019 | 1,019 |
| Retained earnings | -1,733,678 | -1,677,319 | -1,613,431 | -1,558,785 | -1,506,377 |
| Other shareholders' equity | -11 | -8 | -6 | -4 | 41 |
| TOTAL | $-21,736 | $23,958 | $77,570 | $118,843 | $160,112 |
| Total Liabilities And Equity | $243,965 | $273,723 | $305,706 | $352,388 | $404,250 |